By examining RNA-seq data and clinical information from The Cancer Genome Atlas, JM Barajas et al. evaluate the clinical importance of Glucose-6-phosphate dehydrogenase (G6PD) and miR-122 in primary human HCC. This evidence concerns the gene G6PD and hepatocellular carcinoma.